An immigrant from Russia has created a cure for radiation sickness

The U.S. company Cleveland Biolabs has developed a product that can protect people from exposure to radiation.

Until now, doctors could not find a cure for radiation sickness. The only way to prevent the consequences of radiation exposure were iodine pills, which prevent the accumulation of radioactive iodine in the thyroid gland.

However, the drug CBLB502, developed by geneticist Andrew Gudkova of proteins from Salmonella bacteria, a much more efficient. Effects on receptors of cells damaged by radiation, it hinders the process of apoptosis of cells and their mutations.

In laboratory studies on mice and monkeys Gudkova failed to prove that if the irradiated animals receiving the dose of radiation equal to the level of radiation in the explosion of the Chernobyl nuclear power plant, within 72 hours after exposure received medication, 60% of cases survived, and recovering from the effects of exposure.

"Dirty" bomb is considered one of the most terrible threats to humanity, and the Department of National Security of the United States, as reported by Der Spiegel, hastened to jump at the chance to protect United States citizens from possible radiation exposure, invest in the development of the drug 40 million dollars.

In addition, it is assumed that CBLB502 can be used for the treatment of cancer, helping cancer patients cope with the effects of radiotherapy.

The owner of Cleveland Biolabs Israeli Yaakov Reisman, a former combat pilot IDF intends to develop tools and weapons to the security services the Jewish state, where as in the United States to create a stockpile of drugs adequate to protect the civilian population.

Cleveland Biolabs, noting the high interest of pharmaceutical companies around the world for their design, meaning that the annual income from the sale of funds of the order of 20 billion dollars.